MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants

    S.M. Goldman, F. Kamel, C. Meng, M. Korell, D.M. Umbach, J. Hoppin, G.W. Ross, C. Marras, M. Kasten, A. Chade, K. Comyns, D. Sandler, A. Blair, C.M. Tanner (San Francisco, CA, USA)

    Objective: Determine whether variants in the xenobiotic efflux membrane transporter p-glycoprotein gene (ABCB1, p-gp, MDR1) modify the association of rotenone and PD. Background: Use of…
  • 2016 International Congress

    Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease

    I.F. Shih, K.C. Paul, Y. Bordelon, J.M. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: To assess whether and how pre- and postdiagnosis physical activities affect motor function, cognition, and depression among Parkinson's disease (PD) patients. Background: Physical activities…
  • 2016 International Congress

    Do-not-resuscitate utilization in inpatient Parkinson’s disease in the United States

    A. Mahajan, A. Patel, G. Nadkarni, C. Sidiropoulos (Detroit, MI, USA)

    Objective: To investigate Do-not-resuscitate (DNR) order utilization in Parkinson's disease (PD) hospitalizations patients in the United States. Background: DNR order utilization in PD has been…
  • 2016 International Congress

    Assessment of malnutrition in patients with Parkinson’s disease

    O. Yilmaz Kusbeci, I. Inci, B. Donmez Colakoglu, N. Erdogmus Ince, R. Cakmur (Izmir, Turkey)

    Objective: We aimed to assess malnutrition and those at risk of malnutrition in PD patients with an age matched control group using the mini nutritional…
  • 2016 International Congress

    The effect of a structured medication review on quality of life in patients with Parkinson’s disease. An interim analysis

    A. Verbeek, N. Oonk, E. Munster, K. Movig, K. ter Huurne, H. Nijmeijer, J. van der Palen, L. Dorresteijn (Eerbeek, Netherlands)

    Objective: To investigate whether a structured medication review executed by a community pharmacist improves medication adherence and influences quality of life in patients with Parkinson's…
  • 2016 International Congress

    Wrist reveals the fall risk in activities of daily living

    T. Pozaic, R. Foell, A.K. Grebe, W. Stork (Waiblingen, Germany)

    Objective: The focus of our cross-sectional study is on investigation of complex measures in terms of the fall risk (FR). The assessment was performed with…
  • 2016 International Congress

    A 12-month, 2-arm, 2-period, randomized, controlled trial of a digital solution for the management of Parkinson’s disease (PD): Rationale and study design

    S. Papapetropoulos, G. Mitsi (Boston, MA, USA)

    Objective: To collect evidence to support the use of a digital solution to improve health outcomes in PD through remote, timely and appropriate drug adjustments,…
  • 2016 International Congress

    Novel THAP1 missense mutation leading to focal and segmental dystonia

    D. Crosiers, C. Van Broeckhoven, P. Cras (Edegem, Belgium)

    Objective: We have identified a novel heterozygous missense mutation in THAP1 (DYT6 locus) in a patient suffering from craniocervical and upper limb dystonia. We describe…
  • 2016 International Congress

    Familial SPG17/distal hereditary motor neuropathy type V– Complicated hereditary spastic paraplegia with many faces

    T. Musacchio, A.K. Zaum, N. Üceyler, C. Sommer, N. Pfeifroth, K. Reiners, E. Kunstmann, J. Volkmann, S. Rost, S. Klebe (Würzburg, Germany)

    Objective: We present the clinical and genetic results of a SPG17 family with a vast intrafamilial phenotype from subclinical signs to a severe and rapidly…
  • 2016 International Congress

    Reduced thalamo-cortical functional connectivity in asymptomatic LRRK2 mutation carriers

    D. Vilas, B. Segura, C. Pont-Sunyer, M.J. Martí, Y. Compta, F. Valldeoriola, H. Baggio, M. Quintana, A. Bayés, J. Hernández-Vara, M. Calopa, M. Aguilar, C. Junqué, E. Tolosa (Barcelona, Spain)

    Objective: To characterize MRI functional patterns during resting state in asymptomatic LRRK2 mutation carriers. Background: Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley